PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2143334
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2143334
Mouse TNF-a Kit market size was valued at US$ 130.8 Million in 2025, expanding at a CAGR of 6.3% from 2026 to 2033.
The Mouse TNF-a Kit market is basically a set of enzyme-linked immunosorbent assay reagents and devices that enables the quantitative detection of mice's TNF levels in biological fluids such as plasma, serum, and cell culture supernatant. The tool helps to perform the preclinical research investigations at the level of immunology, inflammation, cancer research, and autoimmune diseases by means of the quantitative measurement of the inflammatory cytokine that takes part in the immune response, cell death, and blood vessel formation. The trend toward the development of personalized medicines and targeted immunotherapy increases the need for such kits because they allow for reliable markers of therapy effectiveness. In addition, constant improvement of the assay sensitivity and multiplexing technologies widens the scope of applications of the Mouse TNF-a kit, including the simultaneous measurement of multiple inflammation indicators. Thus making the research in the respective areas easier.
Mouse TNF-a Kit Market- Market Dynamics
Rising Prevalence Of Autoimmune Diseases To Accelerate Market Expansion
The rising prevalence of autoimmune diseases is expected to drive the Mouse TNF-a Kit market forward. Mouse TNF-a kits are used by scientists to quantify TNF-a, which is a protein associated with inflammation and immune response processes. It is important in the analysis of autoimmune diseases, evaluation of therapeutic interventions, and understanding the pathogenesis of the disease. For example, in May 2025, as indicated by Healthdirect Australia (Gov), there has been a hint of an increasing prevalence rate of autoimmune diseases. These autoimmune diseases affect different organs and systems of the body, with the total number of autoimmune diseases being over 80. Furthermore, it has been found out that autoimmune diseases affect about 5% of people, showing the high prevalence rate of these diseases. This growing disease burden is increasing research demand for reliable mouse TNF-a measurement tools.
The Global Mouse TNF-a Kit market is segmented on the basis of Type, Detection Method, Application, End User, Distribution Channel, and Region.
In terms of detection method, colorimetric ELISA holds a notable share in the Mouse TNF-a Kit market because of its wide variety of applications and use for the quantification of TNF in mouse samples, including mouse serums, plasma, and cell culture with visual detection techniques such as color change. In November 2025, R&D Systems from Bio-Techne launched its Mouse TNF-alpha DuoSet ELISA that uses colorimetric detection for the quantification of TNF-alpha in mouse samples. This test provides high sensitivity and accurate quantitation of the TNF-alpha level. This product assists in enhancing the company's portfolio of ELISAs for cytokines and preclinical research.
Mouse TNF-a Kit Market- Geographical Insights
North America holds a prominent place in the Mouse TNF-a Kit market due to the high presence of advanced research in immunology and inflammatory diseases within the region. The region had the high research capability that resulted in high usage of advanced detection kits with high sensitivity to detect low levels of TNF-a, immuno-oncology, and autoimmune disease research. For instance, in August 2026, according to the U.S. Centers for Disease Control and Prevention (Gov), around 4.1 million Americans have ever been diagnosed with inflammatory bowel disease, which accounts for 1.6 percent of all adults, while 3.1 million have ulcerative colitis (1.2%) and 1.3 million have Crohn's disease (0.5%). The disease prevalence is on the increase among adults 18 to 29 years old and is 2.7 percent in adults age 70 years or older. The region's strong research capabilities continue to drive demand for advanced TNF-a detection kits.
China Mouse TNF-a Kit market - Country Insights
China is driving growth in the Asia Pacific market, supported by rising demand for mouse TNF-a kits as well as the increasing investment in immunology and precision medicine. The growing CRO and biotechnology sectors will add more momentum to the use of high-quality kits. In August 2025, according to the MERICS Org. report Lab Leader: China's Rise in Biotechnology, the biotechnology industry in China uses at least CNY 20 billion of publicly funded research dollars, and universities and laboratories in China make up 30% of the world's top academic brainpower.
The nation publishes 61% of the world's most cited scientific publications in synthetic biology, 42% in genomic sequencing and analysis, 30% in new antibiotic and antiviral publications, and 29% in biological manufacturing publications. Biotechnology patents range between 119 and 1,918, and the biotechnology market of the nation is estimated to account for 4.8% of the global biotechnology market. This growth is expected to strengthen demand for advanced mouse TNF-a kits across China's expanding biotechnology ecosystem.
Key players in the Mouse TNF-a Kit market include Thermo Fisher Scientific, Inc.; Bio-Techne Corporation; MilliporeSigma; BD Biosciences; and Sino Biological, Inc., with an aim to enhance their product portfolio and establish their presence in the market. The market for mouse TNF is characterized by cutthroat competition on account of product innovations, alliances, expansion, and partnerships adopted by the market players. In February 2025, Thermo Fisher Scientific announced its agreement to acquire the Purification & Filtration business of Solventum for approximately USD 4.1 billion. Through this, it will be able to broaden its bioprocessing products portfolio through purification and filtration solutions for biologics manufacturing. These strategic initiatives are expected to intensify competition and reinforce players' positions in the market.
In January 2026, BD launched new artificial intelligence capabilities in BD Research Cloud that include automated panel-design capability, which is expected to increase efficiency in scientific research work.